Bausch & Lomb Incorporated
Clinical trials sponsored by Bausch & Lomb Incorporated, explained in plain language.
-
New lens study shows clearer vision after cataract surgery
Disease control CompletedThis study looked at how well enVista Aspire intraocular lenses work in real-world cataract surgery. 335 adults received the lenses during routine cataract removal. Researchers measured vision sharpness and how satisfied patients and surgeons were with the results.
Phase: NA • Sponsor: Bausch & Lomb Incorporated • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Eye redness drops show promise in large trial
Symptom relief CompletedThis completed Phase 3 trial tested a new eye drop containing brimonidine and sodium hyaluronate against Lumify for reducing eye redness in 578 adults. Participants used the drops four times daily, and redness was measured over several hours. The goal was to see if the new drop w…
Phase: PHASE3 • Sponsor: Bausch & Lomb Incorporated • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
Can a new eye drop help contact lens wearers beat dry eye?
Symptom relief CompletedThis study tested whether Miebo eye drops (perfluorohexyloctane) can safely and effectively relieve dry eye symptoms in people who wear soft contact lenses. 104 adults used the drops up to four times daily, both before and while wearing their lenses. Researchers measured changes …
Phase: PHASE4 • Sponsor: Bausch & Lomb Incorporated • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
New eye drops show promise for fast dry eye relief
Symptom relief CompletedThis study tested Miebo eye drops in 99 adults with dry eye disease. Participants used one drop in each eye four times daily for 14 days. The main goal was to see how much dry eye symptoms improved after one week, measured on a 0-to-100 scale. The study is complete, but results a…
Phase: PHASE4 • Sponsor: Bausch & Lomb Incorporated • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC